HZ
GILD icon

Hixon Zuercher’s Gilead Sciences GILD Stock Holding History

Hixon Zuercher’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,629
Closed -$1.33M – 58
2022
Q3 		$1.33M Buy
21,629
+2,435
+13% +$154K 0.85% 38
2022
Q2 		$1.19M Buy
19,194
+907
+5% +$56.2K 0.77% 39
2022
Q1 		$1.09M Buy
18,287
+1,099
+6% +$70.3K 0.58% 44
2021
Q4 		$1.25M Buy
17,188
+1,326
+8% +$91.3K 0.63% 43
2021
Q3 		$1.11M Buy
15,862
+287
+2% +$20.2K 0.65% 44
2021
Q2 		$1.07M Buy
15,575
+200
+1% +$13.4K 0.65% 44
2021
Q1 		$994K Sell
15,375
-23,916
-61% -$1.54M 0.66% 43
2020
Q4 		$2.29M Buy
39,291
+204
+0.5% +$12.3K 1.59% 25
2020
Q3 		$2.47M Buy
39,087
+583
+2% +$40.4K 1.9% 23
2020
Q2 		$2.96M Sell
38,504
-17,533
-31% -$1.34M 2.55% 18
2020
Q1 		$4.19M Buy
56,037
+43,688
+354% +$3.02M 6.04% 5
2019
Q4 		$802K Buy
+12,349
New +$804K 0.76% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hixon Zuercher's GILD Position: Q4 2022 in Review

Hixon Zuercher sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 21,629 shares — an estimated $1.33M sold.

Hixon Zuercher first reported a position in GILD in Q4 2019 and held it in 12 quarters. The position peaked at $4.19M in Q1 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Hixon Zuercher reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Hixon Zuercher sold 21,629 Gilead Sciences shares in Q4 2022, an estimated $1.33M.
  • Hixon Zuercher first reported a position in Gilead Sciences in Q4 2019 and held it in 12 quarters.
  • Hixon Zuercher's Gilead Sciences position peaked at $4.19M in Q1 2020.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Hixon Zuercher's 13F filing for Q4 2022, filed 20 Jan 2023.